PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1501.77%
Revenue growth above 1.5x CSIQ's 0.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
1407.19%
Positive gross profit growth while CSIQ is negative. John Neff would see a clear operational edge over the competitor.
172.69%
Positive EBIT growth while CSIQ is negative. John Neff might see a substantial edge in operational management.
28.26%
Positive operating income growth while CSIQ is negative. John Neff might view this as a competitive edge in operations.
160.27%
Net income growth under 50% of CSIQ's 341.72%. Michael Burry would suspect the firm is falling well behind a key competitor.
160.19%
EPS growth at 50-75% of CSIQ's 264.52%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
160.19%
Diluted EPS growth under 50% of CSIQ's 328.57%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.99%
Negative OCF growth while CSIQ is at 129.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-18.62%
Negative FCF growth while CSIQ is at 34.84%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-86.72%
Negative 10Y revenue/share CAGR while CSIQ stands at 31.08%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-70.29%
Negative 5Y CAGR while CSIQ stands at 47.86%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-47.05%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-136.42%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-2146.53%
Negative 5Y OCF/share CAGR while CSIQ is at 114.91%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2333.49%
Negative 3Y OCF/share CAGR while CSIQ stands at 113.56%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-39.18%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
1647.18%
Positive 5Y CAGR while CSIQ is negative. John Neff might view this as a strong mid-term relative advantage.
434.26%
3Y net income/share CAGR above 1.5x CSIQ's 23.80%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-111.09%
Negative equity/share CAGR over 10 years while CSIQ stands at 223.70%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-2041.68%
Negative 5Y equity/share growth while CSIQ is at 80.66%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-157.67%
Negative 3Y equity/share growth while CSIQ is at 48.20%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
511.98%
AR growth well above CSIQ's 33.34%. Michael Burry fears inflated revenue or higher default risk in the near future.
3542.50%
We show growth while CSIQ is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
33.84%
Positive asset growth while CSIQ is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
31.65%
Positive BV/share change while CSIQ is negative. John Neff sees a clear edge over a competitor losing equity.
-24.35%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
134.10%
SG&A growth well above CSIQ's 48.75%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.